Tumor microenvironment evolution in lung cancer: Spatio-temporal dynamics and clinical implications

Area of Science:

• Oncology
• Cancer Biology

Background:

• Non-small cell lung cancer (NSCLC) treatment has evolved from chemotherapy to targeted therapies and immunotherapies.
• Despite progress, treatment resistance remains a significant clinical challenge in NSCLC management.
• Cancer cell adaptability involves genetic/epigenetic changes and crucial crosstalk with the tumor microenvironment (TME).

Purpose of the Study:

• To highlight the critical role of the tumor microenvironment (TME) in NSCLC progression and treatment response.
• To emphasize the need for understanding TME evolution under therapeutic pressure.
• To underscore the importance of TME dynamics for developing durable NSCLC treatment strategies.

Main Methods:

• Review of current literature on NSCLC treatment strategies.
• Analysis of the components and functions of the tumor microenvironment (TME).
• Exploration of the mechanisms of therapeutic resistance in NSCLC.

Main Results:

• The TME significantly influences NSCLC tumor progression, metastasis, and response to therapy.
• Bidirectional crosstalk between cancer cells and the TME is a key factor in treatment resistance.
• Understanding TME evolution is essential for predicting and overcoming resistance.

Conclusions:

• A comprehensive understanding of the TME's role in NSCLC is vital for advancing treatment.
• Targeting TME dynamics offers a promising avenue for overcoming therapeutic resistance.
• Future NSCLC strategies must integrate TME-focused approaches for improved patient outcomes.